BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21476920)

  • 1. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
    Daly AK; Ballestri S; Carulli L; Loria P; Day CP
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
    Tilg H; Moschen A
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
    Wilfred de Alwis NM; Day CP
    Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease.
    Krawczyk M; Portincasa P; Lammert F
    Semin Liver Dis; 2013 Nov; 33(4):369-79. PubMed ID: 24222094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of genes in nonalcoholic fatty liver disease.
    Day CP
    Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in nonalcoholic steatohepatitis.
    Harmon RC; Tiniakos DG; Argo CK
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease.
    Krawczyk M; Bonfrate L; Portincasa P
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):695-708. PubMed ID: 20955971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genome-wide association studies in hepatology].
    Weber S; Grünhage F; Hall R; Lammert F
    Z Gastroenterol; 2010 Jan; 48(1):56-64. PubMed ID: 20072997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
    Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Bouillet B; Brindisi MC; Robin I; Gambert P; Verges B; Cercueil JP; Hillon P
    Liver Int; 2011 Oct; 31(9):1332-6. PubMed ID: 21745307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
    Day CP
    Liver Int; 2006 Nov; 26(9):1021-8. PubMed ID: 17032401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of alcoholic liver disease.
    Stickel F; Hampe J
    Gut; 2012 Jan; 61(1):150-9. PubMed ID: 22110053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.
    Yoneda M; Hotta K; Nozaki Y; Endo H; Uchiyama T; Mawatari H; Iida H; Kato S; Fujita K; Takahashi H; Kirikoshi H; Kobayashi N; Inamori M; Abe Y; Kubota K; Saito S; Maeyama S; Wada K; Nakajima A
    Liver Int; 2009 Aug; 29(7):1078-85. PubMed ID: 19302184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review.
    Hernaez R
    Gastroenterol Hepatol; 2012 Jan; 35(1):32-41. PubMed ID: 22093607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging genes associated with the progression of nonalcoholic fatty liver disease.
    Koutsari C; Lazaridis KN
    Hepatology; 2010 Sep; 52(3):807-10. PubMed ID: 20812353
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.
    Oliveira CP; Stefano JT; Cavaleiro AM; Zanella Fortes MA; Vieira SM; Rodrigues Lima VM; Santos TE; Santos VN; de Azevedo Salgado AL; Parise ER; Ferreira Alves VA; Carrilho FJ; Corrêa-Giannella ML
    J Gastroenterol Hepatol; 2010 Feb; 25(2):357-61. PubMed ID: 19817962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.